1. EachPod
EachPod
CME in Minutes: Education in Oncology & Hematology - Podcast

CME in Minutes: Education in Oncology & Hematology

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Oncology & Hematology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for oncologists and hematologists to cover the diagnosis, staging, treatment, follow-up, and clinical management of tumors and hematological malignancies. Earning your CME/CE credits has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.

Medicine Science Health & Fitness Life Sciences
Update frequency
every 6 days
Average duration
16 minutes
Episodes
144
Years Active
2022 - 2025
Share to:
Suriya Jeyapalan, MD, MPH  - Improving Patient Outcomes in Newly Diagnosed Glioblastoma: A Focus on Novel Adjuvant Therapies

Suriya Jeyapalan, MD, MPH - Improving Patient Outcomes in Newly Diagnosed Glioblastoma: A Focus on Novel Adjuvant Therapies

Please visit answersincme.com/GVJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neuro-oncology discusses novel…
00:12:30  |   Tue 13 Dec 2022
Charles B. Simone, II, MD, FACRO - Thinking Outside the Box to Advance Cancer Care: The Latest Evidence and Guidance on Novel Portable Electric Field Therapies

Charles B. Simone, II, MD, FACRO - Thinking Outside the Box to Advance Cancer Care: The Latest Evidence and Guidance on Novel Portable Electric Field Therapies

Please visit answersincme.com/PFP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses portable el…
00:15:05  |   Thu 17 Nov 2022
Aditya Bardia, MD, MPH - Reducing Endocrine Resistance in Early Breast Cancer: Will Oral Selective Estrogen Receptor Degraders Provide New Hope?

Aditya Bardia, MD, MPH - Reducing Endocrine Resistance in Early Breast Cancer: Will Oral Selective Estrogen Receptor Degraders Provide New Hope?

Please visit answersincme.com/YZZ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses estrogen re…
00:12:48  |   Tue 15 Nov 2022
Arndt Vogel, MD, PhD - Emerging Trends for Treating Advanced Biliary Tract Cancer: Where Does the Evidence Stand on Immunochemotherapy Combinations

Arndt Vogel, MD, PhD - Emerging Trends for Treating Advanced Biliary Tract Cancer: Where Does the Evidence Stand on Immunochemotherapy Combinations

Please visit answersincme.com/YBC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hepatology discusses the evide…
00:12:57  |   Mon 07 Nov 2022
Eric Jonasch, MD - The Clinical Implications of Current Treatment Options for von Hippel-Lindau Disease

Eric Jonasch, MD - The Clinical Implications of Current Treatment Options for von Hippel-Lindau Disease

Please visit answersincme.com/EZF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the current…
00:12:51  |   Mon 07 Nov 2022
Samuel L. Washington III, MD, MAS - Bridging the Gap in Prostate Cancer Outcomes for Black Men: Elevating Approaches to Androgen Deprivation Therapy

Samuel L. Washington III, MD, MAS - Bridging the Gap in Prostate Cancer Outcomes for Black Men: Elevating Approaches to Androgen Deprivation Therapy

Please visit answersincme.com/DNQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in urology discusses the gap in p…
00:14:04  |   Mon 07 Nov 2022
Peter R. Galle, MD, PhD - Moving Forward with the Management of Unresectable Hepatocellular Carcinoma: Evaluating the Impact of Emerging First-line Dual Immunotherapy Combination Regimens

Peter R. Galle, MD, PhD - Moving Forward with the Management of Unresectable Hepatocellular Carcinoma: Evaluating the Impact of Emerging First-line Dual Immunotherapy Combination Regimens

Please visit answersincme.com/SSF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hepatology discusses the treat…
00:13:06  |   Fri 28 Oct 2022
Ghassan Abou-Alfa, MD, MBA - Leveraging Combinatorial Approaches in Hepatocellular Carcinoma: An Exploration of the Clinical Implications of the Available Data

Ghassan Abou-Alfa, MD, MBA - Leveraging Combinatorial Approaches in Hepatocellular Carcinoma: An Exploration of the Clinical Implications of the Available Data

Please visit answersincme.com/XWC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology, discusses immunother…
00:12:42  |   Fri 28 Oct 2022
Javier Cortés, MD, PhD - BRCA Testing in Patients With Early-Stage Breast Cancer: A Focus on the Patient Conversation

Javier Cortés, MD, PhD - BRCA Testing in Patients With Early-Stage Breast Cancer: A Focus on the Patient Conversation

Please visit answersincme.com/ACJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses BRCA testin…
00:11:19  |   Mon 24 Oct 2022
Aiwu Ruth He, MD, PhD - Reshaping the Landscape of Advanced Biliary Tract Cancer: The Evidence for Combination Immunochemotherapy

Aiwu Ruth He, MD, PhD - Reshaping the Landscape of Advanced Biliary Tract Cancer: The Evidence for Combination Immunochemotherapy

Please visit answersincme.com/BUA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in liver and biliary cancers disc…
00:13:33  |   Thu 20 Oct 2022
Joshua Richter, MD - Charting a New Course in Relapsed/Refractory Multiple Myeloma: The Emergence of BCMA-Targeted Therapies

Joshua Richter, MD - Charting a New Course in Relapsed/Refractory Multiple Myeloma: The Emergence of BCMA-Targeted Therapies

Please visit answersincme.com/CHW860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in hematology/oncology discusses …
00:12:27  |   Fri 14 Oct 2022
Tanios Bekaii-Saab, MD / Beth McLellan, MD - Managing Hand-Foot Skin Reaction: Interdisciplinary Strategies for Patients on Multikinase Inhibitors

Tanios Bekaii-Saab, MD / Beth McLellan, MD - Managing Hand-Foot Skin Reaction: Interdisciplinary Strategies for Patients on Multikinase Inhibitors

Please visit answersincme.com/ERJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts, one in oncology and another in…
00:15:56  |   Tue 04 Oct 2022
Hope S. Rugo, MD, FASCO - Stay in the Know About HER2-Low: Improving Breast Cancer Outcomes with Emerging Antibody Drug Conjugates

Hope S. Rugo, MD, FASCO - Stay in the Know About HER2-Low: Improving Breast Cancer Outcomes with Emerging Antibody Drug Conjugates

Please visit answersincme.com/PHE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in breast oncology discusses the …
00:14:08  |   Tue 04 Oct 2022
David Paul Carbone, MD, PhD - Big Advances in Resectable Non–Small-Cell Lung Cancer With Neoadjuvant Immunotherapy

David Paul Carbone, MD, PhD - Big Advances in Resectable Non–Small-Cell Lung Cancer With Neoadjuvant Immunotherapy

Please visit answersincme.com/NSY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in thoracic oncology discusses ne…
00:14:48  |   Mon 03 Oct 2022
Sagar Lonial, MD - Rebooting the Treatment of Relapsed/Refractory Multiple Myeloma: A New Look at Novel Cereblon-Targeted Agents

Sagar Lonial, MD - Rebooting the Treatment of Relapsed/Refractory Multiple Myeloma: A New Look at Novel Cereblon-Targeted Agents

Please visit answersincme.com/NMC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses rationale f…
00:12:56  |   Fri 30 Sep 2022
Shalina Gupta-Burt, MD - Improving Patient Outcomes in Newly Diagnosed Glioblastoma: Personalizing Treatment and Managing Adverse Events

Shalina Gupta-Burt, MD - Improving Patient Outcomes in Newly Diagnosed Glioblastoma: Personalizing Treatment and Managing Adverse Events

Please visit answersincme.com/EUT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in radiation oncology discusses g…
00:14:12  |   Tue 06 Sep 2022
Orlando M. Gutierrez, MD - Reducing Disparities in Anemia of CKD Management

Orlando M. Gutierrez, MD - Reducing Disparities in Anemia of CKD Management

Please visit answersincme.com/VSA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in nephrology discusses how racia…
00:13:55  |   Mon 05 Sep 2022
George Kassianos, CBE, MD (Hons), FRCGP - A Vaccinator’s Guide to Viral Vector–Based COVID-19 Vaccines

George Kassianos, CBE, MD (Hons), FRCGP - A Vaccinator’s Guide to Viral Vector–Based COVID-19 Vaccines

Please visit answersincme.com/KAG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert on immunization discusses the mec…
00:15:12  |   Fri 02 Sep 2022
Kathleen Moore, MD, MS - Targeting Disease Progression in Advanced Ovarian Cancer: Can Combination PARP Inhibitors and Immune Checkpoint Inhibitors Improve Outcomes?

Kathleen Moore, MD, MS - Targeting Disease Progression in Advanced Ovarian Cancer: Can Combination PARP Inhibitors and Immune Checkpoint Inhibitors Improve Outcomes?

Please visit answersincme.com/AXF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gynecologic cancers discusses …
00:13:49  |   Wed 31 Aug 2022
Antonio González Martin, MD, PhD - Exploring the Evolving Role of PD-1/PD-L1 Inhibitors in Cervical Cancer: Setting Sights on Locally Advanced Disease

Antonio González Martin, MD, PhD - Exploring the Evolving Role of PD-1/PD-L1 Inhibitors in Cervical Cancer: Setting Sights on Locally Advanced Disease

Please visit answersincme.com/BZG860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses new evidenc…
00:12:24  |   Wed 31 Aug 2022
Disclaimer: The podcast and artwork embedded on this page are the property of Answers in CME, 71 Broadway 2B, Suite #185 New York, NY 10006. This content is not affiliated with or endorsed by eachpod.com.